SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020855
Filing Date
2023-05-11
Accepted
2023-05-11 08:01:34
Documents
86
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-20230331.htm   iXBRL 10-Q 3342675
2 EX-10.1 fusn-ex10_1.htm EX-10 309340
3 EX-31.1 fusn-ex31_1.htm EX-31 20390
4 EX-31.2 fusn-ex31_2.htm EX-31 20387
5 EX-32.1 fusn-ex32_1.htm EX-32 11215
6 EX-32.2 fusn-ex32_2.htm EX-32 12023
  Complete submission text file 0000950170-23-020855.txt   12593732

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fusn-20230331_lab.xml EX-101.LAB 583391
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fusn-20230331_cal.xml EX-101.CAL 61614
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fusn-20230331.xsd EX-101.SCH 75200
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fusn-20230331_pre.xml EX-101.PRE 414506
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fusn-20230331_def.xml EX-101.DEF 211505
80 EXTRACTED XBRL INSTANCE DOCUMENT fusn-20230331_htm.xml XML 2473911
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 23908929
SIC: 2836 Biological Products, (No Diagnostic Substances)